Federal Appeals Court Hears Arguments on CAR T-Cell Therapy Patent Dispute

Harris Beach PLLC
Contact
T-Cell Therapies offer enormous promise in the development of novel approaches to treating cancer. A federal appeals court recently heard arguments in a patent dispute between two companies that have emerged as leaders in CAR-T technology for new cancer treatments.

Juno Therapeutics in 2020 won a $1 billion judgment against Gilead’s Kite Pharma in connection with alleged infringement of U.S. Patent No. 7,446,190, entitled “Nucleic Acid Encoding Chimeric T Cell See more +

T-Cell Therapies offer enormous promise in the development of novel approaches to treating cancer. A federal appeals court recently heard arguments in a patent dispute between two companies that have emerged as leaders in CAR-T technology for new cancer treatments.

Juno Therapeutics in 2020 won a $1 billion judgment against Gilead’s Kite Pharma in connection with alleged infringement of U.S. Patent No. 7,446,190, entitled “Nucleic Acid Encoding Chimeric T Cell Receptors.”

The patent relates to a treatment approach that uses specially altered T cells — a part of the immune system — to fight cancer. The invention was developed at Sloan Kettering and licensed to Juno by a Sloan Kettering entity.

In this episode of the Harris Beach Podcast, partner Laura Smalley provides additional background, analyzes the Circuit Court arguments, and gives her thoughts on the implications of the case and what might happen next.

Laura is a member of our Intellectual Property Law Group, with a focus on areas such as patent infringement and litigation, pharmaceuticals, medical devices and life sciences, intellectual property protection and trademarks matters. See less -

Embed
Copy

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Harris Beach PLLC | Attorney Advertising

Written by:

Harris Beach PLLC
Contact
more
less

Harris Beach PLLC on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.